Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

1 source entries across 1 studies. This list may not include all unresolved or historical entries.

  • Oxygen-15 WaterRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

2

all time

Status Distribution
Completed(2)

Detailed Status

Completed2

Development Timeline

Analytics

Development Status

Total Trials
2
Active
0
Success Rate
100.0%

Trials by Status

completed2100%

Recent Activity

0 active trials
Showing 2 of 2
completed

Studies of Frontal Lobe Brain Functioning in Schizophrenia

NCT00001258
completed

Positron Emission Tomography to Measure Pain and Pain Control

NCT00001307

Clinical Trials (2)

Showing 2 of 2 trials
NCT00001258

Studies of Frontal Lobe Brain Functioning in Schizophrenia

Completed
NCT00001307

Positron Emission Tomography to Measure Pain and Pain Control

Completed

All 2 trials loaded

Drug Details

Intervention Type
Drug
Total Trials
2